Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 2
2010 2
2011 3
2012 2
2013 1
2014 4
2015 5
2016 4
2017 8
2018 5
2019 7
2020 9
2021 9
2022 16
2023 12
2024 9
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications.
Pinnetti C, Cimini E, Mazzotta V, Matusali G, Vergori A, Mondi A, Rueca M, Batzella S, Tartaglia E, Bettini A, Notari S, Rubino M, Tempestilli M, Pareo C, Falasca L, Del Nonno F, Scarabello A, Camici M, Gagliardini R, Girardi E, Vaia F, Maggi F, Agrati C, Antinori A. Pinnetti C, et al. Among authors: cimini e. Lancet Infect Dis. 2024 Feb;24(2):e127-e135. doi: 10.1016/S1473-3099(23)00482-6. Epub 2023 Sep 28. Lancet Infect Dis. 2024. PMID: 37778364 Review.
Vδ2 T-cells response in people with Mpox infection: a three-month longitudinal assessment.
Cimini E, Tartaglia E, Messina F, Coppola A, Mazzotta V, Tempestilli M, Matusali G, Notari S, Mondi A, Prota G, Oliva A, Fontana C, Girardi E, Maggi F, Antinori A. Cimini E, et al. Emerg Microbes Infect. 2025 Dec;14(1):2455585. doi: 10.1080/22221751.2025.2455585. Epub 2025 Feb 3. Emerg Microbes Infect. 2025. PMID: 39817429 Free PMC article.
Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good.
Grassi G, Notari S, Gili S, Bordoni V, Casetti R, Cimini E, Tartaglia E, Mariotti D, Agrati C, Sacchi A. Grassi G, et al. Among authors: cimini e. Front Immunol. 2022 Apr 27;13:842949. doi: 10.3389/fimmu.2022.842949. eCollection 2022. Front Immunol. 2022. PMID: 35572540 Free PMC article. Review.
Prolonged survival in HIV-associated Progressive Multifocal Leukoencephalopathy treated with Pembrolizumab: a case series on treatment and long-term follow-up.
Chiuchiarelli M, Micheli G, Segala FV, Giuliano G, Del Giacomo P, Dusina A, Matteini E, Frondizi F, Gaudino S, Lisi F, Cimini E, Santangelo R, Agrati C, Torti C, Cingolani A. Chiuchiarelli M, et al. Among authors: cimini e. J Neurovirol. 2025 Apr;31(2):109-115. doi: 10.1007/s13365-025-01243-0. Epub 2025 Feb 19. J Neurovirol. 2025. PMID: 39971875 Free PMC article.
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study.
Vergori A, Matusali G, Cimini E, Bordi L, Borrelli P, Lanini S, Palazzi R, Paulicelli J, Mariotti D, Mazzotta V, Notari S, Casetti R, Francalancia M, Rosati S, D'Abramo A, Mija C, Mencarini P, Milozzi E, Caraffa E, Sica S, Metafuni E, Sorà F, Rago A, Siniscalchi A, Abruzzese E, Garzia M, Luzi G, Battistini R, Prosperini L, Cingolani A, Girardi E, Maggi F, Antinori A; OCTOPUS Study Group. Vergori A, et al. Among authors: cimini e. Vaccines (Basel). 2024 Jul 17;12(7):784. doi: 10.3390/vaccines12070784. Vaccines (Basel). 2024. PMID: 39066422 Free PMC article.
Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route.
Mazzotta V, Piselli P, Cozzi Lepri A, Matusali G, Cimini E, Esvan R, Colavita F, Gagliardini R, Notari S, Oliva A, Meschi S, Casetti R, Micheli G, Bordi L, Giacinta A, Grassi G, Gebremeskel Tekle S, Cimaglia C, Paulicelli J, Caioli A, Gallì P, Del Duca G, Lichtner M, Sarmati L, Tamburrini E, Mastroianni C, Latini A, Faccendini P, Fontana C, Nicastri E, Siddu A, Barca A, Vaia F, Girardi E, Maggi F, Antinori A; MPOX Vaccine Lazio Study Group. Mazzotta V, et al. Among authors: cimini e. Vaccines (Basel). 2024 Dec 31;13(1):32. doi: 10.3390/vaccines13010032. Vaccines (Basel). 2024. PMID: 39852811 Free PMC article.
Pharmacokinetics of tecovirimat in subjects with Mpox.
Tempestilli M, Mondi A, D'Avolio A, Forini O, Pinnetti C, Mazzotta V, Gagliardini R, Beccacece A, De Nicolò A, Faccendini P, Cimini E, Maggi F, Girardi E, Nicastri E, Boffito M, Vaia F, Antinori A. Tempestilli M, et al. Among authors: cimini e. Int J Antimicrob Agents. 2024 Feb;63(2):107068. doi: 10.1016/j.ijantimicag.2023.107068. Epub 2023 Dec 22. Int J Antimicrob Agents. 2024. PMID: 38141836 Free article.
Tecovirimat concentrations and viral suppression in seminal fluid from patients with mpox.
Tempestilli M, Mondi A, Matusali G, Mariotti D, Pinnetti C, Beccacece A, Cimini E, Mazzotta V, Carletti F, Faccendini P, Maggi F, Girardi E, Nicastri E, Vaia F, Antinori A. Tempestilli M, et al. Among authors: cimini e. Lancet Infect Dis. 2023 May;23(5):531-532. doi: 10.1016/S1473-3099(23)00214-1. Epub 2023 Mar 30. Lancet Infect Dis. 2023. PMID: 37004668 No abstract available.
97 results